FDA Approves Lamisil for Pediatric Treatment of Scalp Ringworm The
FDA Approves Lamisil for Pediatric Treatment of Scalp Ringworm
The U.S. Food and Drug Administration announced the approval of Lamisil Oral Granules for the treatment of tinea capitis, a fungal infection of the scalp, in children ages 4 years and older.